Eyebio - Ownership and Business Overview

Life ScienceCompany

Eyebio Ownership

Who owns Eyebio?

Eyebio is owned by Merck. It was acquired on May 29, 2024.

Eyebio Business Overview

Where is Eyebio headquartered?

Eyebio is headquartered in London, United Kingdom.

What sector is Eyebio in?

Eyebio is a life science company.

When was Eyebio founded?

Eyebio was founded in 2021.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Join Mergr to view all 207 acquisitions of life science companies in 2024, including 21 acquisitions by private equity firms, and 186 by strategics.

Eyebio

Eyebiotech Ltd.

London,
United Kingdom,
www.eyebiotech.com

Eyebio is a clinical-stage, privately held ophthalmology biotechnology company dedicated to developing and delivering a new generation of therapies to protect, restore and improve vision in patients with sight-threatening eye diseases. Eyebio was formed in 2021 and is headquartered in London, England.


 Subscribe to unlock this and 209,235
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.